학술논문

Multi-centre prospective evaluation of cognitive function in patients with metastatic castrate-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) or enzalutamide (ENZ): The ACE study.
Document Type
Article
Source
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p20-20, 235p
Subject
Language
ISSN
0732183X